{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-029166","form_type":"8-K","ticker":"RMTI","cik":"0001041024","company_name":"ROCKWELL MEDICAL, INC.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.987678+00:00","generated_at":"2026-06-11T09:54:58.514914+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Rockwell Medical acquires Evoqua concentrates, raises guidance, expects Q4 profitability","bullets":["Q2 2023 net loss $3.3M ($0.18/sh) vs $5.0M loss ($0.43/sh) in Q2 2022; net sales $18.1M vs $18.7M prior year.","Acquired Evoqua concentrates business for $12.2M; Evoqua generated $18M annual revenue and $3.3M annual EBITDA.","Increased 2023 net sales guidance to $82-86M (from $78-82M) and gross profit guidance to $8-10M (from $7-9M).","Expects to achieve profitability from operations in Q4 2023 and going forward.","Pro forma cash $16.2M after $13.8M warrant exercise and acquisition funding."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-029166","json":"https://secwatch.observer/filing/0001628280-23-029166.json","markdown":"https://secwatch.observer/filing/0001628280-23-029166.md","text":"https://secwatch.observer/filing/0001628280-23-029166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041024/000162828023029166/0001628280-23-029166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041024/000162828023029166/rmti-20230814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:54:58.514914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a4fec36ae39a0238cb443ca065577ba8b2d68b7","claim":"ROCKWELL MEDICAL, INC. updated its the three and six months ended June 30, 2023 guidance (raised).","evidence_excerpt":"On August 14, 2023, Rockwell Medical, Inc. issued a press release and earnings presentation announcing its financial results for the quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828023029166/0001628280-23-029166-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended June 30, 2023"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}